Vir Biotechnology
Develops antibody-based medicines for patients with infectious diseases and cancer
Highlights
- New on EvolcAdded 2026-11-14
About Vir Biotechnology
Vir Biotechnology develops antibody-based medicines using a next-generation antibody platform and PRO-XTEN masking technology. Its pipeline focuses on infectious diseases, including chronic hepatitis delta, and oncology.
The company works to advance treatments from research through clinical development, regulatory approval and commercialization. Its open roles are primarily based in San Francisco, with one U.S. remote position.
Vir describes teams in the United States and Europe. The company marked its 10th anniversary on its website.
Product: Antibody-based therapeutic candidates for infectious diseases and cancer.
Jobs at Vir Biotechnology
More biotech & pharma companies
Vivodyne
Human-tissue experimentation and biological data platform for biopharma drug discovery and therapeutic developmentNew on EvolcWatchmaker Genomics
Enzymes and reagents for NGS library prep and molecular diagnostics, sold to life science researchers and diagnostics developersRemote-friendlyXenon Pharmaceuticals
Develops neuroscience medicines for people with neurological and psychiatric disordersNew on EvolcZentalis
Clinical-stage oncology company developing an oral WEE1 inhibitor, azenosertib, for platinum-resistant ovarian cancerNew on EvolcZoetis
Animal medicines, vaccines, diagnostics and digital solutions for veterinarians, livestock producers and pet owners4D Molecular Therapeutics
Develops gene therapies using customized viral vectors for patients with retinal and lung diseasesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- OneTrustHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- GreenhouseMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.